{
    "Trade/Device Name(s)": [
        "AFIAS iFOB",
        "AFIAS iFOB with AFIAS-50"
    ],
    "Submitter Information": "Immunostics, Inc.",
    "510(k) Number": "K163225",
    "Predicate Device Reference 510(k) Number(s)": [
        "K132167"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OOX"
    ],
    "Summary Letter Date": "July 6, 2017",
    "Summary Letter Received Date": "July 7, 2017",
    "Submission Date": "November 16, 2016",
    "Regulation Number(s)": [
        "21 CFR 864.6550"
    ],
    "Regulation Name(s)": [
        "Occult blood test"
    ],
    "Analyte Class(es)": [
        "immunology",
        "misc"
    ],
    "Analyte(s)": [
        "Fecal Occult Blood",
        "Hemoglobin"
    ],
    "Specimen Type(s)": [
        "Human feces",
        "Fecal samples"
    ],
    "Specimen Container(s)": [
        "Extraction buffer tube",
        "Specimen collection cup",
        "Collection slide"
    ],
    "Instrument(s)/Platform(s)": [
        "AFIAS-50"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence immunoassay",
        "Lateral flow chromatographic assay"
    ],
    "Methodologies": [
        "Antigen-antibody reaction",
        "Fluorescence detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Analyzer",
        "Instrument",
        "Cartridge",
        "Component",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for AFIAS iFOB with AFIAS-50, a fluorescence immunoassay system for qualitative detection of fecal occult blood in human fecal samples",
    "Indications for Use Summary": "Qualitative detection of fecal occult blood in human fecal samples for routine physical examination when gastrointestinal bleeding may be suspected; intended for use in professional clinical and reference laboratories by medical personnel",
    "fda_folder": "Hematology"
}